Aardvark Therapeutics, Inc. Common Stock (AARD) is a publicly traded Healthcare sector company. As of November 13, 2026, AARD trades at $1.34 with a market cap of $34.80M and a P/E ratio of -1.58. AARD moved -11.84% today. Year to date, AARD is -88.36%; over the trailing twelve months it is -85.59%. Its 52-week range spans $0.93 to $17.94. Analyst consensus is neutral with an average price target of $3.00. Rallies surfaces AARD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks AARD insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.34 |
| Market Cap | $34.80M |
| P/E Ratio | -1.58 |
| EPS | $-3.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.94 |
| 52-Week Low | $0.93 |
| Volume | 1.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.35M |
| Net Income | $-69.89M |
| Gross Margin | 0.00% |
9 analysts cover AARD: 0 strong buy, 1 buy, 6 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.00.